Bio- and Chemocatalysis for the Synthesis of Late Stage SAR-Enabling Intermediates for ROMK Inhibitors and MK-7145 for the Treatment of Hypertension and Heart Failure
Rebecca T. Ruck(Merck & Co., Inc., Rahway, NJ, USA (United States)), Fred J. Fleitz(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jongrock Kong(Merck & Co., Inc., Rahway, NJ, USA (United States)), Nelo R. Rivera(Merck & Co., Inc., Rahway, NJ, USA (United States)), Lushi Tan(Merck & Co., Inc., Rahway, NJ, USA (United States)), Qinghao Chen(Washington University in St. Louis), Ian Mangion(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 15
Related Papers
Cobalt-catalyzed asymmetric hydrogenation of enamides enabled by single-electron reduction
|Science|2018|288
Enantioselective α-Arylation of Aldehydes via Organo-SOMO Catalysis. An Ortho-Selective Arylation Reaction Based on an Open-Shell Pathway
|Journal of the American Chemical Society|2009|252
Engineered Ribosyl-1-Kinase Enables Concise Synthesis of Molnupiravir, an Antiviral for COVID-19
|ACS Central Science|2021|197
Hydrogen-Mediated C−C Bond Formation: A Broad New Concept in Catalytic C−C Coupling<sup>1</sup>
|The Journal of Organic Chemistry|2006|172